Related Experiment Video

Updated: Jun 10, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Resistance to transforming growth factor β-mediated tumor suppression in melanoma: are multiple mechanisms in place?

Ahmed Lasfar1, Karine A Cohen-Solal

  • 1Department of Biochemistry and Molecular Biology, University of Medicine and Dentistry of New Jersey-New Jersey Medical School, University Hospital Cancer Center, 205 South Orange Avenue, Newark, NJ 07103, USA.

Carcinogenesis
|July 27, 2010
PubMed

Insights

Melanoma cells can evade transforming growth factor beta (TGFβ) tumor suppression by resisting cell cycle arrest. This review explores known and proposes new resistance mechanisms, impacting melanoma aggressiveness.

Area of Science:

  • Oncology
  • Molecular Biology
  • Dermatology

Background:

  • Transforming growth factor beta (TGFβ) normally suppresses tumors.
  • Melanoma's resistance to TGFβ is key to its aggressiveness.
  • TGFβ can paradoxically promote melanoma oncogenesis.

Purpose of the Study:

  • To review mechanisms of melanoma escape from TGFβ-induced cell cycle arrest.
  • To discuss resistance to TGFβ-mediated apoptosis, which is less understood.
  • To propose novel resistance models based on melanoma signaling pathways.

Main Methods:

  • Review of existing literature on TGFβ signaling and melanoma.
  • Analysis of Smad-dependent and Smad-independent resistance pathways.
  • Integration of data on dysregulated cellular pathways in melanoma.

Main Results:

  • Mechanisms directly impairing Smad2/Smad3 function reduce antiproliferative effects.
  • Alternative pathways can bypass Smad signaling to resist cell cycle arrest.
  • Several models of TGFβ resistance in melanoma have been identified.

Conclusions:

  • Understanding TGFβ resistance is crucial for targeting melanoma aggressiveness.
  • Both Smad-dependent and independent pathways contribute to resistance.
  • Further research into novel resistance mechanisms is warranted for therapeutic strategies.

More Related Videos

Spheroid Assay to Measure TGF-β-induced Invasion09:18

Spheroid Assay to Measure TGF-β-induced Invasion

Published on: November 16, 2011

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...